Related Experiment Video
Updated: Feb 14, 2026

22:06
Derivation of Hematopoietic Stem Cells from Murine Embryonic Stem Cells
Published on: February 25, 2007
14.0K
[Ageing of hematopoietic stem cells]
Hiroko Shiozaki1,2, Ayako Nakamura-Ishizu3, Toshio Suda3
1Shiozaki Medical Clinic.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|February 9, 2018
Summary
Clonal hematopoiesis of indeterminate potential (CHIP) is common in older adults and significantly increases leukemia risk. Senolysis, a novel treatment targeting aging cells, shows promise for preventing these age-related blood cancers.
Area of Science:
- Hematology
- Gerontology
- Oncology
Background:
- Clonal hematopoiesis of indeterminate potential (CHIP) prevalence increases with age.
- CHIP is linked to specific gene mutations and is a precursor to hematopoietic neoplasms.
- Individuals with CHIP have a tenfold higher risk of developing blood cancers.
Purpose of the Study:
- To explore the link between aging, CHIP, and leukemogenesis.
- To investigate the potential of senolysis in managing age-related hematopoietic stem cell aging and cancer development.
Main Methods:
- Genetic analysis to identify CHIP-inducing genes.
- Prevalence studies in elderly populations.
- Preclinical studies on senolysis efficacy in mice models.
Main Results:
- Identified key genes associated with CHIP.
- Demonstrated a tenfold increased risk of hematopoietic neoplasms in CHIP patients.
- Showcased the efficacy of senolysis in removing senescent cells in mice.
Conclusions:
- Understanding CHIP mechanisms is crucial for comprehending aging and leukemogenesis.
- Senolysis presents a promising therapeutic strategy for age-related blood disorders and cancer prevention.
- Clinical translation of senolysis is anticipated in the near future.
Related Concept Videos
Multipotency of Hematopoietic Stem Cells
3.9K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.9K
Regulation of Hematopoietic Stem Cells
4.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.1K
Adult Stem Cells
33.9K
Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.9K
Embryonic Stem Cells
32.7K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.7K
Embryonic Stem Cells
5.3K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
5.3K
Induced Pluripotent Stem Cells
28.2K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.2K

